115
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

UGH Syndrome Resolution after IOL Explantation and Concomitant Carlevale IOL Implantation

, MD, PhDORCID Icon, , MD, PhD, , MD, MSc, , MD, , MD, PhD, , MD, PhD, , MD & , MD, PhDORCID Icon show all
Pages 320-325 | Received 04 Oct 2022, Accepted 12 Jan 2023, Published online: 07 Feb 2023

References

  • Ellingson FT. The uveitis-glaucoma-hyphema syndrome associated with the Mark VIII anterior chamber lens implant. J Am Intraocul Implant Soc. 1978;4(2):50–53. doi:10.1016/S0146-2776(78)80054-8.
  • Van Liefferinge T, Van Oye R, Kestelyn P. Uveitis-glaucoma-hyphema syndrome: a late complication of posterior chamber lenses. Bull Soc Belge Ophtalmol. 1994;252:61–65. discussion 6
  • Aonuma H, Matsushita H, Nakajima K, et al. Uveitis-glaucoma-hyphema syndrome after posterior chamber intraocular lens implantation. Jpn J Ophthalmol. 1997;41(2):98–100. doi:10.1016/S0021-5155(97)00005-1.
  • Badakere SV, Senthil S, Turaga K, Garg P. Uveitis-glaucoma-hyphaema syndrome with in-the-bag placement of intraocular lens. BMJ Case Rep 2016;2016;2016.
  • Durr GM, Ahmed IIK. Intraocular lens complications: decentration, uveitis-glaucoma-hyphema syndrome, opacification, and refractive surprises. Ophthalmology. 2021;128(11):e186–e94. doi:10.1016/j.ophtha.2020.07.004.
  • Yang J, Qiu X, Cai L, et al. Uveitis-glaucoma-hyphema syndrome associated with an in-the-bag square-edge intraocular lens. Precis Clin Med. 2019;2(4):283–287. doi:10.1093/pcmedi/pbz026.
  • Arthur SN, Wright MM, Kramarevsky N, et al. Uveitis-glaucoma-hyphema syndrome and corneal decompensation in association with cosmetic iris implants. Am J Ophthalmol. 2009;148(5):790–793. doi:10.1016/j.ajo.2009.06.008.
  • Cheung AY, Price JM, Heidemann DG, Hart JC Jr. Uveitis-glaucoma-hyphema syndrome caused by dislocated Cionni endocapsular tension ring. Can J Ophthalmol. 2018;53(5):e213–e4. doi:10.1016/j.jcjo.2018.02.021.
  • Bryant TK, Feinberg EE, Peeler CE. Uveitis-glaucoma-hyphema syndrome secondary to a Soemmerring ring. J Cataract Refract Surg. 2017;43(7):985–987. doi:10.1016/j.jcrs.2017.07.002.
  • Zemba M, Camburu G. Uveitis-glaucoma-hyphaema syndrome. General review. Rom J Ophthalmol. 2017;61(1):11–17. doi:10.22336/rjo.2017.3.
  • Armonaite L, Behndig A. Seventy-one cases of uveitis-glaucoma-hyphaema syndrome. Acta Ophthalmol. 2021;99(1):69–74. doi:10.1111/aos.14477.
  • Asaria RH, Salmon JF, Skinner AR, et al. Electron microscopy findings on an intraocular lens in the uveitis, glaucoma, hyphaema syndrome. Eye (Lond). 1997;11(Pt 6):827–829. doi:10.1038/eye.1997.213.
  • Elhusseiny AM, Lee RK, Smiddy WE. Surgical management of uveitis-glaucoma-hyphema syndrome. Int J Ophthalmol. 2020;13(6):935–940. doi:10.18240/ijo.2020.06.12.
  • Barca F, Caporossi T, de Angelis L, et al. Trans-scleral plugs fixated IOL: a new paradigm for sutureless scleral fixation. J Cataract Refract Surg. 2020;46(5):716–720. doi:10.1097/j.jcrs.0000000000000135.
  • Petrou P, Kandarakis S, Papaconstantinou E, et al. Correspondence Re: Veronese et al. Eur J Ophthalmol. 2020 May;30(3):612–615. “New surgical approach for sutureless scleral fixation.” Eur J Ophthalmol 2022;32(1):Np305-np6. 10.1177/1120672120902020.
  • Veronese C, Maiolo C, Armstrong GW, et al. New surgical approach for sutureless scleral fixation. Eur J Ophthalmol. 2020;30(3):612–615. doi:10.1177/1120672120902020.
  • Vaiano AS, Hoffer KJ, Greco A, et al. Long-term outcomes and complications of the new carlevale sutureless scleral fixation posterior chamber IOL. J Refract Surg. 2021;37(2):126–132. doi:10.3928/1081597X-20201207-02.
  • Georgalas I, Spyropoulos D, Gotzaridis S, et al. Scleral fixation of Carlevale intraocular lens: a new tool in correcting aphakia with no capsular support. Eur J Ophthalmol. 2022;32(1):527–533. doi:10.1177/1120672121992978.
  • Christopher KL, Dawson VJ, Kandarakis SA, Ifantides C, Review A. Update on surgical management of intraocular lens dislocation. Int Ophthalmol Clin. 2021;61(1):15–28. doi:10.1097/IIO.0000000000000343.
  • Duchêne M, Iscar C, Muraine M, Gueudry J. [Characteristics and management of uveitis-glaucoma-hyphema syndrome]. J Fr Ophtalmol. 2020;43(3):205–210. doi:10.1016/j.jfo.2019.07.030.
  • Rech L, Heckler L, Damji KF. Serial intracameral bevacizumab for uveitis-glaucoma-hyphema syndrome: a case report. Can J Ophthalmol. 2014;49(6):e160–2. doi:10.1016/j.jcjo.2014.09.010.
  • Singh H, Modabber M, Safran SG, Ahmed II. Laser iridotomy to treat uveitis-glaucoma-hyphema syndrome secondary to reverse pupillary block in sulcus-placed intraocular lenses: case series. J Cataract Refract Surg. 2015;41(10):2215–2223. doi:10.1016/j.jcrs.2015.10.057.
  • Dhillon B, Duff-Lynes SM, Blake CR. A novel method of using transillumination, conjunctival markings and pascal solid state laser to treat uveitis-glaucoma-hyphema syndrome. Am J Ophthalmol Case Rep. 2022;25:101296. doi:10.1016/j.ajoc.2022.101296.
  • Liu Z, Zhang F, Wen Y, et al. Diode laser transscleral cyclophotocoagulation for uveitis-glaucoma-hyphema syndrome: a case report. Medicine (Baltimore). 2020;99(7):e18637. doi:10.1097/MD.0000000000018637.
  • Jasinskas V, Vaiciuliene R, Varoniukaite A, Speckauskas M. Novel microsurgical management of uveitis-glaucoma-hyphema syndrome. Int Ophthalmol. 2019;39(7):1607–1612. doi:10.1007/s10792-018-0972-5.
  • Accorinti M, Saturno MC, Paroli MP, et al. Uveitis-glaucoma-hyphema syndrome: clinical features and differential diagnosis. Ocul Immunol Inflamm. 2022;30(6):1408–1413.
  • Zhang L, Hood CT, Vrabec JP, et al. Mechanisms for in-the-bag uveitis-glaucoma-hyphema syndrome. J Cataract Refract Surg. 2014;40(3):490–492. doi:10.1016/j.jcrs.2013.12.002.
  • Fiore T, Messina M, Muzi A, et al. A novel approach for scleral fixation using Carlevale lens. Eur J Ophthalmol. 2021;31(6):2947–2954. doi:10.1177/1120672121991358.
  • Rouhette H, Meyer F, Pommier S, et al. FIL-SSF Carlevale intraocular lens for sutureless scleral fixation: 7 recommendations from a series of 72 cases. MICA study (multicentric study of the carlevale IOL). J Fr Ophtalmol. 2021;44(7):1038–1046. doi:10.1016/j.jfo.2021.05.002.
  • Bodin S, Bourdon H, Bennedjai A, et al. Efficacy and safety of intraocular folding sutureless scleral fixating lens versus iris-claw intraocular lens implantation. J Fr Ophtalmol. 2022;45(4):392–397. doi:10.1016/j.jfo.2021.11.009.
  • Seknazi D, Colantuono D, Tahiri R, et al. Secondary sutureless posterior chamber lens implantation with two specifically designed IOLs: iris claw lens versus sutureless trans-scleral plugs fixated lens. J Clin Med. 2021;10(10):10. doi:10.3390/jcm10102216.
  • Todorich B, Thanos A, Yonekawa Y, et al. Transconjunctival sutureless intrascleral fixation of secondary intraocular lenses in patients with uveitis. Ocul Immunol Inflamm. 2018;26(3):456–460. doi:10.1080/09273948.2016.1231328.
  • Sousa DC, Leal I, Faria MY, Pinto LA, Rare A. Manifestation of uveitis-glaucoma-hyphema syndrome. J Curr Glaucoma Pract. 2016;10(2):76–78. doi:10.5005/jp-journals-10008-1205.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.